Clinical Trial Update: PAL to Improve Oral Feeding for Infants With Chronic Lung Disease [NA]

View source ↗

Summary

The clinical trial investigating PAL to improve oral feeding in infants with chronic lung disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Lung Disease of Prematurity
• Preterm Birth
• Respiratory Distress Syndrome in Premature Infants

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Chronic Lung Disease of Prematurity, Respiratory Distress Syndrome in Premature Infant | NA | Status: TERMINATED